[{"indications": "Indications\u00a0infections due to beta-lactamase-producing\r\nstrains (where amoxicillin alone not appropriate)\r\nincluding respiratory-tract infections, bone and joint infections,\r\ngenito-urinary and abdominal infections, cellulitis, animal bites,\r\nsevere dental infection with spreading cellulitis or dental infection\r\nnot responding to first-line antibacterial", "name": "CO-AMOXICLAV", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "5 Infections", "5.1 Antibacterial drugs", "5.1.1 Penicillins", "5.1.1.3 Broad-spectrum penicillins", "CO-AMOXICLAV"], "cautions": "Cautions\u00a0see under Ampicillin and notes above; maintain adequate hydration with high doses (particularly during\r\nparenteral therapy); interactions: Appendix\r\n1 (penicillins)Cholestatic jaundice\u00a0Cholestatic\r\njaundice can occur either during or shortly after the use of co-amoxiclav. An epidemiological study has\r\nshown that the risk of acute liver toxicity was about 6 times greater\r\nwith co-amoxiclav than with amoxicillin. Cholestatic jaundice is more common in patients above\r\nthe age of 65 years and in men; these reactions have only\r\nrarely been reported in children. Jaundice is usually self-limiting\r\nand very rarely fatal. The duration of treatment should\r\nbe appropriate to the indication and should not usually exceed 14\r\ndays", "side-effects": "Side-effects\u00a0see under Ampicillin; hepatitis,\r\ncholestatic jaundice (see above); Stevens-Johnson syndrome, toxic\r\nepidermal necrolysis, exfoliative dermatitis, vasculitis reported;\r\nrarely prolongation of bleeding time, dizziness, headache, convulsions\r\n(particularly with high doses or in renal impairment); superficial\r\nstaining of teeth with suspension, phlebitis at injection site", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/85365.htm", "doses": ["By mouth, expressed as co-amoxiclav, one 250/125 strength tablet every 8 hours; increased\r\nin severe infection to one 500/125 strength tablet\r\nevery 8 hours; neonate 0.25\u00a0mL/kg of 125/31 suspension every 8 hours; child 1 month\u20131 year, 0.25\u00a0mL/kg of 125/31 suspension\r\nevery 8 hours, dose doubled in severe infection; 1\u20136 years, 5\u00a0mL of 125/31 suspension every 8 hours or 0.25\u00a0mL/kg\r\nof 125/31 suspension every 8 hours, dose doubled\r\nin severe infection; 6\u201312 years, 5\u00a0mL of 250/62 suspension\r\nevery 8 hours or 0.15\u00a0mL/kg of 250/62 suspension every 8 hours, dose doubled in severe infection", "Severe dental infections (but not generally first-line, see notes above), expressed\r\nas co-amoxiclav, adult and child over 12 years, one 250/125 strength tablet every 8 hours for 5 days", "By intravenous injection over 3\u20134\r\nminutes or by intravenous infusion, expressed as co-amoxiclav, 1.2\u00a0g every 8 hours; neonate 30\u00a0mg/kg every 12 hours; child 1\u20133 months 30\u00a0mg/kg every 12 hours; child 3 months\u201318 years, 30\u00a0mg/kg (max. 1.2\u00a0g) every 8 hours", "Surgical prophylaxis, expressed as co-amoxiclav, 1.2\u00a0g up to 30 minutes before the procedure; for high risk procedures\r\nup to 2\u20133 further doses of 1.2\u00a0g may be given every 8 hours"], "pregnancy": "Pregnancy\u00a0not known to be harmful"}, {"indications": "Indications\u00a0infections due to beta-lactamase-producing\r\nstrains (where amoxicillin alone not appropriate)\r\nincluding respiratory-tract infections, bone and joint infections,\r\ngenito-urinary and abdominal infections, cellulitis, animal bites,\r\nsevere dental infection with spreading cellulitis or dental infection\r\nnot responding to first-line antibacterial", "name": "CO-AMOXICLAV Other oral preparations", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "5 Infections", "5.1 Antibacterial drugs", "5.1.1 Penicillins", "5.1.1.3 Broad-spectrum penicillins", "CO-AMOXICLAV", "Other oral preparations"], "cautions": "Cautions\u00a0see under Ampicillin and notes above; maintain adequate hydration with high doses (particularly during\r\nparenteral therapy); interactions: Appendix\r\n1 (penicillins)Cholestatic jaundice\u00a0Cholestatic\r\njaundice can occur either during or shortly after the use of co-amoxiclav. An epidemiological study has\r\nshown that the risk of acute liver toxicity was about 6 times greater\r\nwith co-amoxiclav than with amoxicillin. Cholestatic jaundice is more common in patients above\r\nthe age of 65 years and in men; these reactions have only\r\nrarely been reported in children. Jaundice is usually self-limiting\r\nand very rarely fatal. The duration of treatment should\r\nbe appropriate to the indication and should not usually exceed 14\r\ndays", "side-effects": "Side-effects\u00a0see under Ampicillin; hepatitis,\r\ncholestatic jaundice (see above); Stevens-Johnson syndrome, toxic\r\nepidermal necrolysis, exfoliative dermatitis, vasculitis reported;\r\nrarely prolongation of bleeding time, dizziness, headache, convulsions\r\n(particularly with high doses or in renal impairment); superficial\r\nstaining of teeth with suspension, phlebitis at injection site", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/204235.htm", "doses": ["By mouth, expressed as co-amoxiclav, one 250/125 strength tablet every 8 hours; increased\r\nin severe infection to one 500/125 strength tablet\r\nevery 8 hours; neonate 0.25\u00a0mL/kg of 125/31 suspension every 8 hours; child 1 month\u20131 year, 0.25\u00a0mL/kg of 125/31 suspension\r\nevery 8 hours, dose doubled in severe infection; 1\u20136 years, 5\u00a0mL of 125/31 suspension every 8 hours or 0.25\u00a0mL/kg\r\nof 125/31 suspension every 8 hours, dose doubled\r\nin severe infection; 6\u201312 years, 5\u00a0mL of 250/62 suspension\r\nevery 8 hours or 0.15\u00a0mL/kg of 250/62 suspension every 8 hours, dose doubled in severe infection", "Severe dental infections (but not generally first-line, see notes above), expressed\r\nas co-amoxiclav, adult and child over 12 years, one 250/125 strength tablet every 8 hours for 5 days", "By intravenous injection over 3\u20134\r\nminutes or by intravenous infusion, expressed as co-amoxiclav, 1.2\u00a0g every 8 hours; neonate 30\u00a0mg/kg every 12 hours; child 1\u20133 months 30\u00a0mg/kg every 12 hours; child 3 months\u201318 years, 30\u00a0mg/kg (max. 1.2\u00a0g) every 8 hours", "Surgical prophylaxis, expressed as co-amoxiclav, 1.2\u00a0g up to 30 minutes before the procedure; for high risk procedures\r\nup to 2\u20133 further doses of 1.2\u00a0g may be given every 8 hours", "Name[Co-amoxiclav (Non-proprietary) ] Suspension \u2018400/57\u2019, co-amoxiclav 400/57 (amoxicillin 400\u00a0mg as trihydrate, clavulanic\r\nacid 57\u00a0mg as potassium salt)/5\u00a0mL when reconstituted with water,\r\nnet price 35\u00a0mL = \u00a34.13, 70\u00a0mL = \u00a35.79. \r\n    Label:\r\n    9 Excipients  may include aspartame (section 9.4.1)Note\u00a0Sugar-free versions are available and can\r\nbe ordered by specifying \u2018sugar-free\u2019 on the prescriptionBrands include Augmentin-Duo\u00aeDose\u00a0adult and child over 40\u00a0kg 10\u00a0mL twice daily, increased to\r\n10\u00a0mL three times daily in severe infection; child 2 months\u20132 years 0.15\u00a0mL/kg twice daily, 2\u20136 years (13\u201321\u00a0kg) 2.5\u00a0mL\r\ntwice daily, 7\u201312 years (22\u201340\u00a0kg) 5\u00a0mL twice daily, doubled in severe\r\ninfection"], "pregnancy": "Pregnancy\u00a0not known to be harmful"}]